Finland investigates 17 cases of narcolepsy associ
Finland investigates 17 cases of narcolepsy associated with influenza vaccine.
Helsinki, August 26 .- The National Institute of Health and Welfare of Finland (THL) is investigating the possible relationship between H1N1 influenza vaccine "Pandemrix", manufactured by the pharmaceutical company GlaxoSmithKline, and the appearance of 17 recent cases of narcolepsy in children and adolescents.
So far, health authorities have confirmed that six children became ill with narcolepsy in Finland after receiving, STO gold, the vaccine and suspect that may be at least eleven other related cases, but have not yet completed medical reports.
These cases account for at least six other similar reported in Sweden, where authorities have also ordered an inquiry was opened to determine if they have any connection with the vaccine.
The fear that the "Pandemrix" may cause narcolepsy, a neurological disease that, star trek online gold, causes extreme daytime sleepiness, has been responsible for THL to suspend the vaccination until after the investigation.
According to this agency, about 90 million people worldwide have been vaccinated with "Pandemrix", of which more than 4 million were children.
The H1N1 influenza epidemic, considered the first pandemic of the XXI century, led to the Finnish authorities to buy 5.28 million vaccines, one for each inhabitant of the Nordic countries, the pharmaceutical GlaxoSmithKline, with a total cost of about 37 million euros.